Trial Profile
A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2014
Price :
$35
*
At a glance
- Drugs Porfiromycin (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 10 Jul 2014 New trial record